Robert A Rissman
Overview
Explore the profile of Robert A Rissman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
205
Citations
7921
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ketron G, Grun F, Grill J, Feldman H, Rissman R, Brewer G
Alzheimers Res Ther
. 2025 Mar;
17(1):59.
PMID: 40069789
Background: Nicotinamide, a form of B3 vitamin, is an NAD precursor that reduces pTau levels via histone deacetylase inhibition in murine models of Alzheimer's disease (AD). A recent phase 2a...
2.
Petersen M, Zhang F, Hall J, Brock C, Rissman R, Como T, et al.
Alzheimers Dement (N Y)
. 2025 Feb;
11(1):e70045.
PMID: 39975470
Introduction: Alzheimer's disease (AD) biomarkers of Amyloid(A), Tau(T), and Neurodegeneration(N) have been increasingly studied to fill the gap in our understanding of racial and ethnic differences. This study aimed to...
3.
Ashton N, Keshavan A, Brum W, Andreasson U, Arslan B, Droescher M, et al.
Alzheimers Dement
. 2025 Feb;
21(2):e14508.
PMID: 39907496
Introduction: The Alzheimer's Association Global Biomarker Standardization Consortium conducted a blinded case-control study to learn which phosphorylated tau (p-tau) assays provide the largest fold-changes in Alzheimer's disease (AD) versus non-AD...
4.
El-Agnaf O, Overk C, Rockenstein E, Mante M, Florio J, Adame A, et al.
Neurobiol Dis
. 2025 Jan;
206:106788.
PMID: 39818529
No abstract available.
5.
Wolk D, Nelson P, Apostolova L, Arfanakis K, Boyle P, Carlsson C, et al.
Alzheimers Dement
. 2025 Jan;
21(1):e14202.
PMID: 39807681
Limbic predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) is highly prevalent in late life and a common co-pathology with Alzheimer's disease neuropathologic change (ADNC). LATE-NC is a slowly progressive, amnestic...
6.
Ng T, Udeh-Momoh C, Lim M, Gleerup H, Leifert W, Ajalo C, et al.
Alzheimers Dement
. 2024 Dec;
21(2):e14420.
PMID: 39737743
There is a pressing need for accessible biomarkers with high diagnostic accuracy for Alzheimer's disease (AD) diagnosis to facilitate widespread screening, particularly in underserved groups. Saliva is an emerging specimen...
7.
Grill J, Tam S, Thai G, Vides B, Pierce A, Green K, et al.
Neurology
. 2024 Dec;
104(1):e210152.
PMID: 39671543
Background And Objectives: Nicotinamide is a coenzyme involved in cellular oxidation-reduction reactions that can inhibit Class III histone deacetylases (HDACs) or sirtuins. HDAC inhibition can affect numerous therapeutic pathways, including...
8.
Sukreet S, Goodwill V, Ngolab J, Kim H, Leisher S, Salehi S, et al.
J Neuropathol Exp Neurol
. 2024 Oct;
84(2):168-173.
PMID: 39471466
No abstract available.
9.
Avalos B, Kulbe J, Ford M, Laird A, Walter K, Mante M, et al.
Viruses
. 2024 Oct;
16(10.
PMID: 39459844
Triggering receptor expressed on myeloid cells 2 (TREM2) is involved in neuroinflammation and HIV-associated neurocognitive impairment (NCI). People with HIV (PWH) using cannabis exhibit lower inflammation and neurological disorders. We...
10.
Ghandian S, Albarghouthi L, Nava K, Sharma S, Minaud L, Beckett L, et al.
bioRxiv
. 2024 Oct;
PMID: 39386601
Accumulation of abnormal tau protein into neurofibrillary tangles (NFTs) is a pathologic hallmark of Alzheimer disease (AD). Accurate detection of NFTs in tissue samples can reveal relationships with clinical, demographic,...